Table 4.
Median with Interquartile range (IQR) of intact and degranulated Mast cells in groups
| Group | Intact Mast cells | Degranulated Mast cells | |
|---|---|---|---|
| Control | Day 4 Day 7 Day 15 |
14(7-18)① 3(2-4) 3(1-3) |
4(0-6)③ 4(2-6) 0(0-1)④ |
| Eucerin-treated | Day 4 Day 7 Day 15 |
6(5-12) 2(1-3) 2(2-3) |
8(2-9) 3(2-6) 1(0-2) |
| White tea 5% ointment-treated | Day 4 Day 7 Day 15 |
3(2-4.5)① 2(1.5-3.5) 2(2-3) |
8(5-9.5) 5(3-6) 0(0-1) |
| Gel-treated | Day 4 Day 7 Day 15 |
4(4-4) 4(4-4) 2(1-2)② |
6(3-7) * 0(0-1)④ |
| White tea 5% gel-treated | Day 4 Day 7 Day 15 |
2(2-3)① 3(3-7) 3.5(3-4.75)② |
9(7-16)③ 5(5-9) 2.5(1.25-3)④ |
On day 4, intact Mast cells of control group were significantly (p<0.05) more than intact Mast cells of white tea 5% ointment-treated group and white tea 5% gel treated group (①).
On day 15, intact Mast cells of white tea 5% gel treated group were significantly (p<0.05) more than intact Mast cells of gel-treated group (②).
On day 4, degranulated Mast cells of white tea 5% gel treated group were significantly (p<0.05) more than degranulated Mast cells of control group (③).
On day 15, degranulated Mast cells of white tea 5% gel treated group were significantly (p<0.05) more than degranulated Mast cells of control group and gel-treated group (④).
*: IQR was not calculable due to the lack of enough data.